People in the News

May 17, 2017

Stanley Lapidus

Aushon BioSystem has appointed Stanley Lapidus to its board of directors. He brings more than three decades of experience founding and leading breakthrough diagnostic companies. Lapidus founded and served as CEO for Cytyc, now part of Hologic, in the late 80's.  After Cytic, he founded Exact Sciences where he served as CEO until 2001 and chairman until 2005. He also was both founder and CEO of SynapDx and Helicos Biosciences.

May 17, 2017

John Marshall

Caris Life Sciences has appointed John Marshall as its chief medical officer. In this role, Marshall will direct the company's oncology research efforts, guide clinical strategies for innovative precision medicine and tumor profiling services, and continue to serve as chairman of the Caris Centers of Excellence for Precision Medicine Network. He currently serves as associate director for clinical care at the Georgetown Lombardi and chief of the division of hematology-oncology at MedStar Georgetown University Hospital. Marshall is also the founding director of Georgetown Lombardi's Otto J. Ruesch Center for the Cure of Gastrointestinal Cancer.

May 15, 2017

Wendy Rubinstein

Wendy Rubinstein has been named the first division director for clinical data management and curation of CancerLinQ, a nonprofit subsidiary of the American College of Clinical Oncology. In this newly created role, Rubinstein will lead all clinical data quality and data curation at CancerLinQ. Rubinstein previously served as chief of medical genetics and human variation at the NIH National Center for Biotechnology Information, director of the NIH Genetic Testing Registry, and in various leadership positions at NorthShore University HealthSystem in Evanston, Illinois.

May 11, 2017

Jeffrey Edwards, Arnold Pinkston, Gregory Hinckley

Bio-Rad has elected three new board members — Jeffrey Edwards, Gregory Hinckley, and Arnold Pinkston — at its annual shareholders meeting. 

Jeffrey Edwards previously served as CEO of Allergan from 2005 to August 2014, and retired from the company in 2015 after 22 years

Arnold Pinkston previously served as executive vice president and general counsel for Allergan, senior vice president and general counsel for Beckman Coulter, and vice president and deputy general counsel at Eli Lilly.

Gregory Hinckley currently serves as president of Mentor Graphics, a supplier of products and services used for the design of electronic content, and has 30 years of public company experience.

The newly-elected members replace Louis Drapeau, Robert Malchione, Joel McComb and Deborah Neff, who declined to stand for reelection due to disagreements with Bio-Rad's management regarding executive personnel and corporate governance matters, according to a Securities and Exchange Commission filing. In a statement, Bio-Rad noted that their decision not to stand for reelection was not related to any issues regarding the integrity of the company's financial statements or accounting policies and practices.

May 11, 2017

Steven Sepulveda

Mesa Biotech has appointed Steven Sepulveda vice president of global business development and channel management. Sepulveda will be responsible for directing and overseeing all aspects of commercial global sales, business development, strategic alliances, and distributor relationship management. He has 26 years of experience in the IVD business with companies such as Quidel, Beckman Coulter, and Sekisui Diagnostics.

May 11, 2017

John Kraeutler

John Kraeutler will retire as CEO from Meridian Bioscience as part of a planned transition as soon as the firm finds his successor. He will remain as executive chairman of Meridian's board of directors and will be available to assist the new CEO during the transition and onboarding phase, the firm said in a statement. Kraeutler joined the company as CEO in 1992.

May 11, 2017

Madhuri Hegde

PerkinElmer has appointed Madhuri Hegde as VP and chief scientific officer for its newly created Laboratory Services group. In this role, Hegde will oversee the laboratory services group to ensure the delivery of innovative solution to clinical and healthcare system customers, the company said. She joins PerkinElmer from Emory Genetics Lab where she served as chief scientific officer and executive director.

May 10, 2017

Elisha Finney

NanoString Technologies has appointed Elisha Finney to its Board of Directors and Audit Committee. A former executive vice president and chief financial officer at Varian Medical Systems, Finney brings more than 25 years of financial and life science expertise, the company said. Finney also currently serves on the board of directors at ICU Medical and at iRobot, and she previously served as a board member for Altera Corporation, Thoratec, and Laserscope. She earned her BA in risk management and insurance from the University of Georgia and her MBA from Golden Gate University in San Francisco.

May 10, 2017

Herman Verrelst

Biocartis has appointed Herman Verrelst as its new CEO, effective as of August. Herman currently holds the position of VP and general manager of the genomics and clinical applications division of Agilent Technologies. He joined Agilent from Cartagenia, where he served as CEO and founder until it's acquisition by Agilent. He also served as CEO of Medicim, which was acquired by Swiss-based Nobel Biocare, in addition to serving as CEO and founder of DATA4s, which was acquired by Norkom Technologies.

May 09, 2017

Michael Rodriguez

GenomeDx Biosciences appointed Michael Rodriguez as CFO, effective immediately. He was an advisor and CFO at Crossover Health. Prior to that, he was CFO at Epic Sciences and chief operating officer at Clarient Diagnostic Services. 

May 08, 2017

Bob Watson, Sandeep Reddy

NantHealth President and Chief Growth Officer Bob Watson is leaving the firm and will become a consultant to the company. The company said Watson is relocating to the East Coast for family reasons. The company also appointed Sandeep Reddy its chief medical officer. In his post, he will oversee education, outreach, clinical development programs, and clinical trials for the firm's GPS Cancer test. Reddy joined NantHealth in 2016 as senior executive director of medical affairs. Prior to that, he was CMO at Caris Life Sciences. 

May 05, 2017

Marco Piccinini, Asaho Takei

Fluidigm has appointed Marco Piccinini as commercial lead for Europe and Asaho Takei as general manager in Japan, Fluidigm President and CEO Chris Linthwaite announced during the company's Q1 earnings call this week. Piccinini has held senior commercial leadership positions at PerkinElmer, Applied Biosystems, Life Technologies, and Thermo Fisher Scientific. Takei previously worked for Illumina for more than 15 years.

May 04, 2017

Thomas Bauer, D. Kyle Hogarth, Edward Patz, Anil Vachani

OncoCyte has established a medical advisory committee of lung cancer specialists to help guide the firm on issues related to the diagnosis of the illness. The committee comprises Thomas Bauer, a thoracic surgery specialist at Meridian Health, and former associate professor of surgery at Jefferson Medical College; and D. Kyle Hogarth, an associate professor of medicine at the University of Chicago and medical director of the pulmonary rehabilitation program, director of bronchoscopy and minimally invasive diagnostics, and codirector of upper aerodigestive cancer risk clinic. Also on the committee are Edward Patz, a James and Alice Chen Professor of radiology, and professor in pathology and in pharmacology and cancer biology at the Duke University School of Medicine, where he is also a director of the molecular diagnostics laboratory; and Anil Vachani, a pulmonologist and assistant professor of medicine at the Hospital of the University of Pennsylvania and the Veteran's Administration Medical Center.

May 04, 2017

José Baselga, Brook Byers, Kaye Foster

Grail has appointed José Baselga, Brook Byers, and Kaye Foster to its board of directors. They will join currently serving board members Bill Rastetter, Jeff Huber, Richard Klausner, and Robert Nelsen. Baselga is the physician-in-chief and chief medical officer at Memorial Sloan Kettering Cancer Center, and professor of medicine at Weill Cornell Medical College. He also serves as the chairman of Grail's Scientific Advisory Board. Byers is a senior partner and founding member of Kleiner Perkins Caufield & Byers (KPCB). Foster currently advises CEOs and leadership teams focusing on business transformations, talent management strategy, and human resources strategy development and implementation. She most recently served as senior VP of Global Human Resources for Onyx Pharmaceuticals.

May 04, 2017

Gail Marcus

Natera has appointed Gail Marcus to its board of directors. Marcus currently serves assistant professor, and director of the global healthcare management and biomedical informatics programs at the Massachusetts College of Pharmacy and Health Sciences. She also currently serves on the Centers for Medicare and Medicaid Services Advisory Panel on Clinical Diagnostic Laboratory Tests. Previously, she served as president and CEO of Caris Diagnostics, and has held a variety of leadership roles in multiple companies including Caremark, UnitedHealthcare, and Cigna.

May 02, 2017

Travis Lacey, Dale Gordon, Gary Altman, Steven Ness

Human Longevity has hired several new senior staff. Travis Lacey was named chief corporate development officer; Dale Gordon was named chief commercial officer; Gary Altman was named chief operating officer; and Steven Ness was named chief services lead. Lacey comes from GE Healthcare where he was the managing director, leading the divestiture practice and portfolio optimization. Before that he was with investment banks Jefferies and R.W. Baird. Gordon was most recently GM of account management at GE Healthcare. Prior to that, he was with EMD Millipore, now Millipore Sigma and part of Merck KGaA. Altman has more than 25 years of experience leading startups and has served as CEO, COO, VP, and GM at various firms. Ness most recently was director of client services at GE Healthcare's Clarient Diagnostics business. Previously, he held medical affairs and marketing positions at Quidel. 

May 02, 2017

Kuniko Nishikawa

Analytics firm Fronteo Healthcare has chosen Kuniko Nishikawa as its new CEO. Nishikawa had been an independent director of the healthcare subsidiary of Tokyo-based Fronteo Inc. since December. She replaces previous CEO Naritomo Ikeue, who has agreed to remain on the board of directors, overseeing business development for Fronteo Healthcare. The company also named Masahiro Morimoto executive chairman. 

May 02, 2017

Darlene Deptula-Hicks

T2 Biosystems has appointed Darlene Deptula-Hicks senior VP and CFO. Deptula-Hicks was most recently CFO and senior vice president at Pieris Pharmaceuticals, and has served as CFO for a variety of biotech and medical device companies. She also is a board member of Xenetic Biosciences. Deptula-Hicks is filling the post left vacant after Shawn Lynch resigned from T2 in March.

May 01, 2017

Gajus Worthington

Former Fluidigm Cofounder, President, and CEO Gajus Worthington has joined the Chan Zuckerberg Biohub as chief operating officer. He was with Fluidigm from 1999 to 2016. Before that he held various engineering, marketing, and management positions at Actel. 

Apr 28, 2017

Mary Tedd Allen

Nanostring has appointed Mary Tedd Allen as its senior vice president of operations, effective May 1, 2017. Currently the firm's vice president of operations, Allen also served as Nanostring's VP of manufacturing. Prior to joining the company, she was director of research and programs at the Washington Technology Center, and before that she served as vice president of the advanced manufacturing and development group at Applied Biosystems. She holds a BA in chemistry from Mount Holyoke College and a PhD in chemistry from the University of Rochester.
Apr 27, 2017

Tina Nova

OpGen has appointed Tina Nova to its board of directors. Nova currently serves as president and CEO of newly formed molecular diagnostics company Molecular Stethoscope, and most recently served as senior vice president and general manager of Illumina's oncology business unit. From 2000 to 2014, Nova was cofounder, director, president, and CEO of Genoptix Medical Laboratory, which was purchased by Novartis for nearly $500,000 in 2011. She has also held senior positions with Nanogen, Ligand Pharmaceuticals, and Hybritech. She currently serves on the board of Arena Pharmaceuticals and Veracyte, and is vice chairman of the board for the newly formed Rady Pediatric Genomics and Systems Medicine Institute.

Apr 26, 2017

Rich Gray

N-of-One has appointed Rich Gray as VP of business development. In this position, he will lead direct and channel sales teams to further develop partnerships to provide clinical interpretation on a broader scale. Gray has served in various executive sales and marketing roles at organization such as Altos, now part of Flatiron Health; the IntelliDose division of IntrinsiQ, now a division of AmerisourceBergen; and Medical Systems Management, now part of Optum.

Apr 26, 2017

Jamie L’Heureux

Progeny Genetics, a Delray Beach, Florida-based subsidiary of Ambry Genetics, has promoted Jamie L’Heureux to CEO. L'Heureux had been a software project manager at the company since 2014 and previously worked as a contractor for Progeny. She also has 12 years of experience as a board-certified genetic counselor.

Apr 25, 2017

Vicki DiFrancesco

Xifin has appointed Vicki DiFrancesco as its chief strategy officer. DiFrancesco has more than 25 years of experience in executive leadership positions and most recently served as president and CEO of Pathology Inc., a women's health laboratory acquired by Laboratory Corporation of America last year. 

Apr 20, 2017

Bill Bonello

NeoGenomics has appointed Bill Bonello as VP, treasurer, and director of corporate development. Prior to joining NeoGenomics, Bonello served as senior research analyst at Craig Hallum Capital Markets, and as senior research analyst for RBC Capital Markets. He has also served as senior VP of investor relations for Laboratory Corporation of America, managing director of equity research at Wachovia Capital Markets, and managing director of equity research at Piper Jaffray.

Pages

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.